Q3 Revenue Tops $1B as Net Income Jumps 1,782%, FY Guidance Narrowed
ASTH has more than doubled off its 52-week low of $18.08.
Summary
Astrana posted record Q3 revenue of $1,023.6 million, up 7% year over year, with net income attributable to the company of $13.0 million versus $0.4 million a year ago and diluted EPS of $0.26. Adjusted EBITDA rose 13% to $77.2 million, though adjusted EPS of $0.71 was only up 4% from $0.68 — the headline net income jump is largely a low prior-year base, not a step-change in underlying profitability. The company narrowed full-year 2026 guidance to revenue of $3.9-4.0 billion, adjusted EBITDA of $261-274 million and free cash flow of $107.5-130 million, and introduced Q4 revenue guidance of $939-1,039 million. Nine-month operating cash flow of $117.1 million and free cash flow of $105.4 million came in roughly flat versus last year despite the revenue growth, a gap worth pressing management on. This follows the September 8-Ks that reaffirmed FY2026 revenue and free cash flow guidance and the September disclosure of a material cybersecurity incident; the unremediated internal-control weakness flagged in the Q2 10-Q remains an open risk. The 2:30 p.m. PT call today is where guidance cadence and the cash conversion question get tested.
At the time of this announcement, ASTH was trading at $39.01 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $18.08 to $51.60. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: PR Newswire.